JP2004538258A5 - - Google Patents

Download PDF

Info

Publication number
JP2004538258A5
JP2004538258A5 JP2002572418A JP2002572418A JP2004538258A5 JP 2004538258 A5 JP2004538258 A5 JP 2004538258A5 JP 2002572418 A JP2002572418 A JP 2002572418A JP 2002572418 A JP2002572418 A JP 2002572418A JP 2004538258 A5 JP2004538258 A5 JP 2004538258A5
Authority
JP
Japan
Prior art keywords
compound
subject
group
wrinkle
induction
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2002572418A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004538258A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CA2002/000363 external-priority patent/WO2002073208A2/en
Publication of JP2004538258A publication Critical patent/JP2004538258A/ja
Publication of JP2004538258A5 publication Critical patent/JP2004538258A5/ja
Withdrawn legal-status Critical Current

Links

JP2002572418A 2001-03-13 2002-03-13 抗癲癇誘発剤 Withdrawn JP2004538258A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US27561801P 2001-03-13 2001-03-13
PCT/CA2002/000363 WO2002073208A2 (en) 2001-03-13 2002-03-13 Anti-epileptogenic agents

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2007150044A Division JP2007302678A (ja) 2001-03-13 2007-06-06 抗癲癇誘発剤

Publications (2)

Publication Number Publication Date
JP2004538258A JP2004538258A (ja) 2004-12-24
JP2004538258A5 true JP2004538258A5 (https=) 2006-01-12

Family

ID=23053121

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2002572418A Withdrawn JP2004538258A (ja) 2001-03-13 2002-03-13 抗癲癇誘発剤
JP2007150044A Pending JP2007302678A (ja) 2001-03-13 2007-06-06 抗癲癇誘発剤

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2007150044A Pending JP2007302678A (ja) 2001-03-13 2007-06-06 抗癲癇誘発剤

Country Status (8)

Country Link
US (1) US20030194375A1 (https=)
EP (1) EP1386166A2 (https=)
JP (2) JP2004538258A (https=)
CN (1) CN1774635A (https=)
CA (1) CA2440834A1 (https=)
IL (1) IL157845A0 (https=)
MX (1) MXPA03008164A (https=)
WO (1) WO2002073208A2 (https=)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040208875A1 (en) * 1995-03-15 2004-10-21 Queen's University At Kingston Method for treating amyloidosis
CA2369997C (en) * 1999-04-28 2009-11-17 Queen's University At Kingston Compositions and methods for treating amyloidosis
AU5994900A (en) * 1999-07-09 2001-01-30 Isis Innovation Limited Compounds for inhibiting diseases and preparing cells for transplantation
US8329924B2 (en) * 2001-06-11 2012-12-11 Vertex Pharmaceuticals (Canada) Incorporated Compounds and methods for the treatment or prevention of Flavivirus infections
CN101624391A (zh) * 2001-06-11 2010-01-13 病毒化学医药公司 用作黄病毒感染抗病毒剂的噻吩衍生物
US7355042B2 (en) 2001-10-16 2008-04-08 Hypnion, Inc. Treatment of CNS disorders using CNS target modulators
NI200300043A (es) 2002-03-28 2003-11-05 Warner Lambert Co AMINOACIDOS CON AFINIDAD POR LA PROTEINA a2DELTA.
US20070010573A1 (en) 2003-06-23 2007-01-11 Xianqi Kong Methods and compositions for treating amyloid-related diseases
US7244764B2 (en) 2003-06-23 2007-07-17 Neurochem (International) Limited Methods and compositions for treating amyloid-related diseases
BRPI0414798A (pt) * 2003-09-25 2006-11-21 Warner Lambert Co métodos para usar aminoácidos com afinidade para a proteìna alfa2delta
JP2007538080A (ja) * 2004-05-17 2007-12-27 オデッサ ファーマ，エルエルシー α−ケト分岐鎖アミノ酸を用いた脳神経細胞内グルタミン酸レベルの低減
WO2006085149A2 (en) 2004-12-22 2006-08-17 Neurochem (International) Limited Methods and compositions for treating amyloid-related diseases
TW200716088A (en) * 2005-04-15 2007-05-01 Neurochem Int Ltd Formulations and methods for treating amyloidosis
US20070049638A1 (en) * 2005-07-21 2007-03-01 Neurochem (International) Limited Polymorphic forms of 3-amino-1-propanesulfonic acid
EP1968561B8 (en) * 2005-12-22 2010-10-20 Kiacta Sàrl Treatment of diabetic nephropathy
PT2089417E (pt) 2006-10-12 2015-04-14 Bhi Ltd Partnership Métodos, compostos, composições e veículos para administrar o ácido 3-amino-1-propanossulfónico
WO2008078176A1 (en) * 2006-12-22 2008-07-03 Bellus Health (International) Limited Methods, compounds, and compositions for treating metabolic disorders and diabetes
WO2009079373A2 (en) 2007-12-14 2009-06-25 The Regents Of The University Of California Inhibitors of calcium-activated chloride channels
WO2009100431A1 (en) * 2008-02-07 2009-08-13 Marquette University Cysteine and cystine prodrugs to treat schizophrenia and reduce drug cravings

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2461842A (en) * 1943-02-26 1949-02-15 Sharples Chemicals Inc Condensation of nitriles with amides and the production of beta-alanine
NZ194348A (en) * 1979-07-26 1982-09-14 Merrell Toraude & Co Fluorinated methyl-beta-alanine derivatives and pharmaceutical compositions
US4255448A (en) * 1979-09-10 1981-03-10 Wisconsin Alumni Research Foundation Method for reducing epileptiform activity
JPS6124552A (ja) * 1984-07-13 1986-02-03 Kuraray Co Ltd γ−アミノ酪酸誘導体およびその製造法
US4906779A (en) * 1986-07-10 1990-03-06 State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University N,N'-disubstituted guanidines and their use as excitatory amino acid antagonists
DE3737399A1 (de) * 1987-11-04 1989-05-18 Schwabe Willmar Gmbh & Co Aminosaeureester, verfahren zu ihrer herstellung und ihre verwendung
WO1990001027A1 (fr) * 1988-07-18 1990-02-08 Yamasa Shoyu Kabushiki Kaisha 1-amino-5-halogeno-uraciles, procede de preparation de ces composes, et agents depresseurs du systeme nerveux central les contenant en tant qu'ingredients actifs
GB8926512D0 (en) * 1989-11-23 1990-01-10 Pfizer Ltd Therapeutic agents
US5648369A (en) * 1991-11-20 1997-07-15 University Of Kentucky Research Foundation Aminoalkylpyridine compounds which are useful as anitconvulsant drugs, excitatory amino acid inhibitors and NMDA sigma receptor antagonists
US6306909B1 (en) * 1997-03-12 2001-10-23 Queen's University At Kingston Anti-epileptogenic agents

Similar Documents

Publication Publication Date Title
JP2004538258A5 (https=)
JP2005526011A5 (https=)
JP5645830B2 (ja) トラマドールとｎｓａｉｄとの共結晶
Garner et al. Butorphanol-mediated antinociception in mice: partial agonist effects and mu receptor involvement
US6306909B1 (en) Anti-epileptogenic agents
Contreras et al. Stereotyped behavior correlates better than ataxia with phencyclidine-receptor interactions
JP2004517813A5 (https=)
HRP20120154T1 (hr) HETEROCIKLIČKI INHIBITORI MEK-a I METODE NJIHOVE UPORABE
KR910000659A (ko) 이미다졸릴-알케노산
JP2003525933A5 (https=)
JP2002520274A (ja) バルサルタンとカルシウムチャンネルブロッカーの抗高血圧組合わせ
EP1020185A3 (de) Opioide Analgetika mit kontrollierter Wirkstofffreisetzung
ATE509935T1 (de) Mischungen aus mono-carboxylfunktionalisierten dialkylphosphinsäuren, ein verfahren zu ihrer herstellung und ihre verwendung
JP2004504347A5 (https=)
ZA200708835B (en) Age inhibitors
US20030194375A1 (en) Anti-epileptogenic agents
JPS5587771A (en) 1-phenylisoquinoline derivative
JP2009539822A5 (https=)
JP2008533063A5 (https=)
Deprez et al. New potent calcimimetics: II. Discovery of benzothiazole trisubstituted ureas
ZA200300514B (en) Novel compounds and their use as glycine transport inhibitors.
JP2003532724A (ja) ソマトスタチン誘導体に親和性を有する、ヒダントイン誘導体
TW427973B (en) Novel compounds as excitatory amino acid receptor antagonists, process for the preparation thereof, and pharmaceutical compositions comprising the compounds
JP2000516257A5 (https=)
RU2009104060A (ru) Новые оптически активные соединения фенилэтаноламинов и способ их получнеия